Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | MMP1 | P03956 | 1/20 | 0.43 |
| ▸ | MMP3 | P08254 | 1/20 | 0.43 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10086332 | 1.00 | LMNA (0.50) | LMNAMEN1KMT2ACA2NPC1 | |
| SCHEMBL13398403 | 0.88 | MEN1 (0.47) | LMNAMEN1KMT2ACA2NPC1 | |
| SCHEMBL27549589 | 0.88 | MEN1 (0.47) | LMNAMEN1KMT2ACA2NPC1 | |
| SCHEMBL16316818 | 0.86 | MEN1 (0.48) | LMNAMEN1KMT2ACA2NPC1 | |
| SCHEMBL6139152 | 0.86 | MEN1 (0.48) | LMNAMEN1KMT2ACA2NPC1 | |
| SCHEMBL11205081 | 0.86 | MEN1 (0.48) | LMNAMEN1KMT2ACA2NPC1 | |
| SCHEMBL28774121 | 0.85 | ITGA4 (0.47) | LMNAMEN1KMT2ACA2RAB9A | |
| SCHEMBL28774123 | 0.85 | ITGA4 (0.47) | LMNAMEN1KMT2ACA2RAB9A | |
| SCHEMBL6575563 | 0.85 | ALDH1A1 (0.46) | LMNAMEN1KMT2ACA2NPC1 | |
| SCHEMBL22338701 | 0.83 | MEN1 (0.49) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9040626-B2 | Nanofibers and morphology shifting micelles | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-05-26 | — | — | US | disclosed |
| US-20120149843-A1 | NANOFIBERS AND MORPHOLOGY SHIFTING MICELLES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120149843-A1 | NANOFIBERS AND MORPHOLOGY SHIFTING MICELLES | MFAP1, LGALS4, TLN1 | LMNA 62/4885MEN1 412/4885KMT2A 2800/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.